Relmada Therapeutics RLMD
NASDAQ RLMD
$3.27 -0.02 (-0.61%)
At close: Oct 23, 2026 · 4:00 PM EDT

Relmada Therapeutics (RLMD) Price to Sales (2015 - 2023)

Updated

Analysis

Relmada Therapeutics (RLMD) Price to Sales (2015 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Relmada Therapeutics 348.81 Mn -209.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 27.78
Sep 30, 2023 20.97
Jun 30, 2023 22.77
Mar 31, 2023 29.58
Dec 31, 2022 50.65
Sep 30, 2022 1,030.76
Jun 30, 2022 788.15
Dec 31, 2019 472.17
Dec 31, 2017 38.99
Sep 30, 2017 21.56
Mar 31, 2017 9,505.19
Dec 31, 2016 9,078.99
Sep 30, 2016 11,842.56
Jun 30, 2016 15,706.86
Mar 31, 2016 31,290.31
Dec 31, 2015 13,773.09
Sep 30, 2015 12,386.82
Jun 30, 2015 22,079.01
Mar 31, 2015 33,114.46
API Access

Relmada Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=RLMD&period=max&api_key=YOUR_API_KEY